SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-032952
Filing Date
2023-09-25
Accepted
2023-09-25 17:11:20
Documents
14
Period of Report
2023-09-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20230925.htm   iXBRL 8-K 25599
6 ardx-20230925_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-23-032952.txt   193992

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20230925.xsd EX-101.SCH 2155
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20230925_def.xml EX-101.DEF 15269
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20230925_lab.xml EX-101.LAB 29722
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20230925_pre.xml EX-101.PRE 15971
8 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20230925_htm.xml XML 3294
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 231276529
SIC: 2834 Pharmaceutical Preparations